pyrroles has been researched along with pentoxifylline in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oda, M; Yamamoto, N; Yamashita, A; Yokota, K | 1 |
| Ahlers, CM; Biswas, DK; Dezube, BJ; Pardee, AB | 1 |
| Baba, M; Gohnai, K; Hashimoto, K; Sato, M; Shigeta, S | 1 |
| Carper, HT; Mandell, GL; Sullivan, GW | 1 |
| Biswas, DK; LaVecchio, J; Marasco, WA; Mhashilkar, AM; Pardee, AB | 1 |
| Georgescu, EF; Georgescu, M | 1 |
| Araújo, AC; Jorge, VC; Noronha, C; Panarra, A; Riso, N; Vaz Riscado, M | 1 |
1 trial(s) available for pyrroles and pentoxifylline
| Article | Year |
|---|---|
Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study.
Topics: Adult; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Cholagogues and Choleretics; Fatty Liver; Female; Hematologic Agents; Hepatitis; Heptanoic Acids; Humans; Losartan; Male; Middle Aged; Pentoxifylline; Pyrroles; Treatment Outcome; Ursodeoxycholic Acid | 2007 |
6 other study(ies) available for pyrroles and pentoxifylline
| Article | Year |
|---|---|
The effects of KBT-3022, a new anti-platelet agent, on hemorheological properties in guinea pigs.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Animals; Aspirin; Blood Viscosity; Diphosphoglyceric Acids; Drug Evaluation, Preclinical; Erythrocyte Deformability; Fibrinogen; Guinea Pigs; Hematocrit; Hemorheology; Pentoxifylline; Plasma; Platelet Aggregation Inhibitors; Pyrroles; Thiazoles; Ticlopidine | 1995 |
Cooperative inhibition of NF-kappa B and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat.
Topics: Antiviral Agents; Benzodiazepines; Cell Line; Drug Synergism; Gene Expression Regulation, Viral; Gene Products, tat; HIV Long Terminal Repeat; HIV-1; Humans; NF-kappa B; Pentoxifylline; Pyrroles; tat Gene Products, Human Immunodeficiency Virus | 1993 |
Heat shock induces HIV-1 replication in chronically infected promyelocyte cell line OM10.1.
Topics: Alkaloids; Antibodies; Antiviral Agents; Benzodiazepinones; Cell Line; Enzyme Inhibitors; Gene Products, tat; Granulocytes; Heat-Shock Response; HIV-1; Humans; NF-kappa B; Pentoxifylline; Protein Kinase C; Pyrroles; Staurosporine; tat Gene Products, Human Immunodeficiency Virus; Tumor Necrosis Factor-alpha; Virus Activation | 1996 |
The specific type IV phosphodiesterase inhibitor rolipram combined with adenosine reduces tumor necrosis factor-alpha-primed neutrophil oxidative activity.
Topics: Adenosine; Carbazoles; Drug Synergism; Humans; In Vitro Techniques; Indoles; Neutrophils; Pentoxifylline; Phenethylamines; Phosphodiesterase Inhibitors; Pyrroles; Pyrrolidinones; Respiratory Burst; Rolipram; Superoxides; Tumor Necrosis Factor-alpha | 1995 |
Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
Topics: Anti-HIV Agents; Benzodiazepines; Carbazoles; CD4-Positive T-Lymphocytes; Cell Line; Gene Products, tat; HIV Antibodies; HIV Long Terminal Repeat; HIV-1; Humans; Indoles; Jurkat Cells; Leukocytes, Mononuclear; NF-kappa B; Pentoxifylline; Phytohemagglutinins; Pyrroles; tat Gene Products, Human Immunodeficiency Virus; Time Factors; Transcriptional Activation; Transfection; Tumor Necrosis Factor-alpha; Virus Replication | 1997 |
Buerger's disease (Thromboangiitis obliterans): a diagnostic challenge.
Topics: Adult; Angiography; Aspirin; Atorvastatin; Calcium Channel Blockers; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iloprost; Male; Nifedipine; Pentoxifylline; Platelet Aggregation Inhibitors; Pyrroles; Smoking Cessation; Thromboangiitis Obliterans | 2011 |